YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Earnings Call Insights: CapsoVision, Inc. (CV) Q2 2026 MANAGEMENT VIEW * “The second quarter represented another period of steady progress for CapsoVision as we continued executing our commercial strategy while advancing several important…
Key Points Interested in CapsoVision, Inc.? Here are five stocks we like better. Second-quarter revenue rose 10% to $3.6 million, driven by a 13% increase in CapsoCam Plus capsule sales and shipments of 8,845 units. More than 176,000 patie…
* CapsoVision, Inc. press release [https://seekingalpha.com/pr/20619065-capsovision-reports-second-quarter-2026-financial-results] (CV [https://seekingalpha.com/symbol/CV]): Q2 GAAP EPS of -$0.15 misses by $0.02. * Revenue of $3.64M (+9.6%…
(RTTNews) - CRISPR Therapeutics (CRSP), a gene editing company, reported financial results for the second quarter of 2026, reflecting a narrower net loss. In addition, the company provided an update on the clinical pipeline. Read on to unp…
(RTTNews) - CapsoVision, Inc. (CV), a commercial-stage medical technology company, announced the launch of AI Highlights for the CapsoCam Plus system to support physician review of small bowel capsule endoscopy studies. CapsoVision focuses…
SARATOGA, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced the international lau…
VAN BUREN TOWNSHIP, Mich., July 23, 2026 /PRNewswire/ -- Visteon Corporation (NASDAQ: VC) today reported second quarter financial results. Highlights include:Visteon Logo Sales of $960 million with Growth-over-Market of 4%1 Net income attr…
SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, announced the appointment of David S.…
Key Points Interested in CapsoVision, Inc.? Here are five stocks we like better. CapsoVision reported Q1 revenue of $2.8 million, flat year over year, while capsule shipments slipped 3% due to order timing; management said the lower volume…
Earnings Call Insights: CapsoVision (CV) Q1 2026 MANAGEMENT VIEW * "CapsoVision remains focused on advancing earlier, more accurate and more accessible detection of gastrointestinal disease for patients worldwide," said Co-Founder, Preside…
* CapsoVision, Inc. press release [https://seekingalpha.com/pr/20516432-capsovision-reports-first-quarter-2026-financial-results] (CV [https://seekingalpha.com/symbol/CV]): Q1 GAAP EPS of -$0.15 misses by $0.02. * Revenue of $2.8M misses b…
The United States market has been flat over the last week but is up 30% over the past year, with earnings forecast to grow by 16% annually. In this environment, growth companies with significant insider ownership can be appealing as they o…
[Close Up Image Of A Stock Market Graph] solarseven/iStock via Getty Images Benchmark Equity Research on Tuesday released its quarterly update to the firm’s “best ideas” list, featuring 29 high-conviction, catalyst-driven stock picks selec…
CapsoVision logo Key Points CapsoCam Plus is gaining commercial momentum, with management citing roughly 15% full‑year revenue growth, about 9,400 Q4 patients (12% YoY) and over 161,000 patients imaged to date, driven by its wire‑free 360°…
(RTTNews) - CapsoVision, Inc. (CV), a commercial-stage medical technology company, on Friday announced the closing of a $14 million private placement and preliminary fourth-quarter and full-year 2025 financial results. Company Profile Caps…
SARATOGA, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (the “Company”) (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced the…
As U.S. markets navigate a landscape of rising Treasury yields and uncertainty surrounding Federal Reserve policies, investors are keenly observing insider activities as a potential indicator of confidence in company growth prospects. In t…
CapsoVision, Inc. CV recently announced that it has submitted a 510(k) application to the FDA for approval to add an AI-based reading feature to its CapsoCam Plus capsule endoscopy system. The proposed AI feature is designed to improve the…
(RTTNews) - CapsoVision, Inc. (CV), a commercial-stage medical technology company developing imaging and AI-enabled capsule endoscopy solutions, announced the submission of its 510(k) application to the FDA seeking clearance for its propri…
SARATOGA, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that Johnny Wang, Pre…
(RTTNews) - CapsoVision, Inc. (CV) on Thursday reported its financial results for the third quarter ended September 30, 2025. The company reported a net loss of $7.9 million or $0.17 per share, compared with a net loss of $5.8 million or $…
CapsoVision SARATOGA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial…
CapsoVision Seasoned finance executive brings public company, capital markets and transaction experience to support next phase of growth SARATOGA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage…
SARATOGA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the company will…
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025, at the Metropolitan C…
SARATOGA, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that Johnny Wang, Pr…
Analysts at ATB Capital Markets and Desjardins raised their price targets on Cenovus Energy Inc. (CV PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
* CapsoVision, Inc. press release [https://seekingalpha.com/pr/20201913-capsovision-reports-second-quarter-2025-financial-results] (NASDAQ:CV [https://seekingalpha.com/symbol/CV]): Q2 GAAP EPS of -$2.02 misses by $1.91. * Revenue of $3.32M…
Company Logo The 360 Quadrants analysis highlights the leaders in the global Smart Pills market, evaluating over 102 companies. Smart pills, also known as ingestible sensors or digital pills, offer revolutionary diagnostic functions and me…
SARATOGA, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”) technologies that are deployed in its capsu…
Investing.com -- CapsoVision , Inc. (NASDAQ:CV), a commercial-stage medical technology company, began trading on the Nasdaq Capital Market on Tuesday. Shares opened at the initial offering price of $5, but have since fallen 12% to $4.40, a…
[Human hand and small capsule endoscope] Yuuji/iStock via Getty Images * CapsoVision (CV [https://seekingalpha.com/symbol/CV]) has priced [https://seekingalpha.com/pr/20154370-capsovision-announces-pricing-of-initial-public-offering]its in…
SARATOGA, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”) technologies that are deployed in its capsu…
SAN FRANCISCO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Sunrun Inc. (NASDAQ: RUN), the nation's leading provider of residential solar, storage and energy services, today announced that Mary Powell, a Sunrun Director and former President and CEO o…
SAN FRANCISCO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Sunrun Inc. (NASDAQ: RUN), the nation's leading provider of residential solar, storage and energy services, today announced that Mary Powell, a Sunrun Director and former President and CEO o…